IGC Pharma (IGC) EPS (Basic) (2010 - 2025)
IGC Pharma's (IGC) quarterly EPS (Basic) came in at -$0.02 in Q3 2025, up 10.89% year-over-year from -$0.02 in Q3 2024, and up 40.24% quarter-over-quarter from -$0.03 in Q2 2025.
Powered by 
Analysis
IGC Pharma (IGC) EPS (Basic) (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has reported EPS (Basic) for 16 consecutive years, with -$0.02 the latest figure, recorded in Q3 2025.
- On a quarterly basis, EPS (Basic) rose 10.89% year-over-year to -$0.02 in Q3 2025; TTM through Sep 2025 was -$0.08, a 34.71% increase from a year earlier, with the FY2026 full-year figure at -$0.02, up 59.53% from the prior year.
- EPS (Basic) was -$0.02 for Q3 2025 at IGC Pharma, up from -$0.03 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.0 in Q1 2024 and troughed at -$0.09 in Q4 2023.
- A 5-year average of -$0.04 and a median of -$0.04 in 2021 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) sank 1398.87% in 2021 and surged 91.42% in 2024, its largest moves.
- Over 5 years, EPS (Basic) stood at -$0.05 in 2021, then increased by 9.12% to -$0.04 in 2022, then sank by 106.93% to -$0.09 in 2023, then surged by 73.14% to -$0.02 in 2024, then gained by 14.55% to -$0.02 in 2025.
- The last three EPS (Basic) figures came in at -$0.02 (Q3 2025), -$0.03 (Q2 2025), and -$0.02 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -0.40 |
| 10 | IGC Pharma | 27.77 Mn | 27.51 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -0.02 |
| Jun 30, 2025 | -0.03 |
| Mar 31, 2025 | -0.02 |
| Dec 31, 2024 | -0.02 |
| Sep 30, 2024 | -0.02 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | -0.09 |
| Sep 30, 2023 | -0.05 |
| Jun 30, 2023 | -0.04 |
| Mar 31, 2023 | -0.03 |
| Dec 31, 2022 | -0.04 |
| Sep 30, 2022 | -0.05 |
| Jun 30, 2022 | -0.05 |
| Mar 31, 2022 | -0.07 |
| Dec 31, 2021 | -0.05 |
| Sep 30, 2021 | -0.09 |
| Jun 30, 2021 | -0.04 |
| Mar 31, 2021 | -0.03 |
| Dec 31, 2020 | -0.06 |